LSAG
AZN icon

Lake Street Advisors Group’s AstraZeneca AZN Stock Holding History

Lake Street Advisors Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$621K Sell
4,742
-596
-11% -$83.4K 0.03% 297
2024
Q3 		$832K Sell
5,338
-157
-3% -$25.3K 0.04% 242
2024
Q2 		$857K Sell
5,495
-94
-2% -$14.1K 0.04% 239
2024
Q1 		$757K Buy
5,589
+762
+16% +$101K 0.04% 267
2023
Q4 		$650K Sell
4,827
-331
-6% -$43K 0.03% 286
2023
Q3 		$699K Sell
5,158
-172
-3% -$23.5K 0.04% 184
2023
Q2 		$763K Buy
5,330
+254
+5% +$37.4K 0.04% 186
2023
Q1 		$705K Sell
5,076
-188
-4% -$25.3K 0.04% 178
2022
Q4 		$714K Sell
5,264
-119
-2% -$14.9K 0.05% 167
2022
Q3 		$590K Buy
+5,383
New +$683K 0.04% 178
2021
Q3 		– Sell
-6,200
Closed -$713K – 244
2021
Q2 		$713K Buy
6,200
+756
+14% +$82.9K 0.05% 135
2021
Q1 		$541K Sell
5,444
-101
-2% -$10.2K 0.04% 150
2020
Q4 		$554K Sell
5,545
-5,848
-51% -$619K 0.05% 145
2020
Q3 		$1.25M Buy
11,393
+2,766
+32% +$308K 0.12% 76
2020
Q2 		$913K Buy
8,627
+4,273
+98% +$441K 0.09% 93
2020
Q1 		$389K Buy
4,354
+774
+22% +$72.9K 0.05% 136
2019
Q4 		$357K Buy
3,580
+357
+11% +$33.6K 0.04% 153
2019
Q3 		$287K Buy
3,223
+324
+11% +$28.1K 0.03% 159
2019
Q2 		$239K Sell
2,899
-155
-5% -$12.2K 0.03% 182
2019
Q1 		$247K Buy
3,054
+360
+13% +$28.4K 0.03% 180
2018
Q4 		$205K Buy
+2,694
New +$210K 0.03% 185
2018
Q3 		– Sell
-2,861
Closed -$201K – 227
2018
Q2 		$201K Hold
2,861
– – 0.02% 314
2018
Q1 		$200K Buy
+2,861
New +$198K 0.02% 296

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Lake Street Advisors Group's AZN Position: Q4 2024 in Review

Lake Street Advisors Group reduced its AstraZeneca (AZN) stake by 11% in Q4 2024, selling an estimated $83.4K and leaving 4,742 shares worth $621K. The position accounts for 0.03% of the portfolio, ranked #297.

Lake Street Advisors Group first reported a position in AZN in Q1 2018 and has held it in 23 quarters since. The position peaked at $1.25M in Q3 2020. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Lake Street Advisors Group held 4,742 shares of AstraZeneca worth $621K as of Q4 2024.
  • Lake Street Advisors Group sold 596 AstraZeneca shares in Q4 2024, an estimated $83.4K.
  • AstraZeneca made up 0.03% of Lake Street Advisors Group's portfolio in Q4 2024, its #297 holding.
  • Lake Street Advisors Group first reported a position in AstraZeneca in Q1 2018 and has held it in 23 quarters since.
  • Lake Street Advisors Group's AstraZeneca position peaked at $1.25M in Q3 2020.
  • 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.